Morning Overview on MSNOpinion
Top expert claims Alzheimer’s might not actually start in the brain
For more than a century, Alzheimer’s disease has been framed as a slow catastrophe that begins inside the brain and stays ...
While all medications carry potential side effects, certain types have been shown to increase the risk of falls, confusion ...
About 25% of Medicare beneficiaries with dementia were prescribed high-risk central nervous system (CNS) – active medications associated with falls, confusion and hospitalizations between 2013 and ...
MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. The neuro-focused company is penning a strategic collaboration meant to develop new therapies for ...
Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...
DUBLIN--(BUSINESS WIRE)--The "Central Nervous System Therapeutics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Central Nervous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback